BPG is committed to discovery and dissemination of knowledge
Correspondence
Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 118615
Published online Jun 27, 2026. doi: 10.4254/wjh.118615
Figure 1
Figure 1 Microplastics and nanoplastics may induce and exacerbate metabolic dysfunction-associated steatotic liver disease by causing lysosomal dysfunction, thereby impairing the late stages of bulk and selective autophagy, such as lipophagy, and blocking autophagic flux. MPs: Microplastics; NPs: Nanoplastics; MASLD: Metabolic dysfunction-associated steatotic liver disease.


Write to the Help Desk